Physician

Achilles Theodore Paparsenos, M.D.

According to 2025 Medicare claims, Achilles Paparsenos, M.D. (NPI: 1487858015) practices endocrinology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is BUCKS THYROID & ENDOCRINE CARE LLC (NPI: 1639549785; TIN: 474464055) and primary practice location at 19067-7725.

Paparsenos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 508 traditional Medicare patients, billed 1,119 HCPCS/CPT codes, and received $85,972 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 5,674 prescription claims across 677 beneficiaries totaling $3,007,769 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 595 claims. Open Payments data shows 160 records totaling $37,405. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,009,035 to $3,007,769. For DME billing, reported payments moved sharply higher in recent years, from $10,137 to $202,529.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	709	4,184	$109,711
2016	225	485	$44,086
2017	316	682	$58,046
2018	377	786	$60,550
2019	399	798	$64,067
2020	412	784	$56,923
2021	427	902	$82,010
2022	417	941	$79,158
2023	439	974	$85,601
2024	508	1,119	$85,972

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	436	4,402	$1,009,035
2016	418	3,059	$733,809
2017	374	3,067	$1,022,839
2018	433	3,710	$1,365,620
2019	458	3,807	$1,639,166
2020	523	4,377	$1,942,880
2021	563	4,514	$2,257,215
2022	581	4,869	$2,688,914
2023	621	5,338	$3,275,539
2024	677	5,674	$3,007,769

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	213	646	$23,479
2016	134	398	$15,308
2017	81	308	$31,235
2018	128	399	$38,697
2019	140	533	$83,869
2020	110	597	$105,455
2021	156	803	$157,033
2022	151	872	$171,998
2023	200	1,094	$223,915
2024	176	595	$215,671

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	118	118	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	322	571	$86
76536	Ultrasound scan of head and neck soft tissue	49	51	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	118	136	$55
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	83	174	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	552	24,110	$861,186
Ozempic	Semaglutide	409	19,416	$620,516
Humulin R U-500 Kwikpen	Insulin Regular, Human	136	5,968	$233,038
Tresiba Flextouch U-200	Insulin Degludec	165	10,011	$168,152
Jardiance	Empagliflozin	141	8,259	$154,251

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	86	362	$182,274
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	26	$17,186
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	11	34	$9,163
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	12	35	$3,240
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	11	11	$2,252

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	160	$37,405	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Achilles Theodore Paparsenos, M.D.?

Tedicare shows public-source Medicare data for Achilles Theodore Paparsenos, M.D. (NPI 1487858015), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Achilles Theodore Paparsenos, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Achilles Theodore Paparsenos, M.D.?

Achilles Theodore Paparsenos, M.D. is linked to BUCKS THYROID & ENDOCRINE CARE LLC (billing NPI 1639549785) in the available physician profile data.

Does Achilles Theodore Paparsenos, M.D. have Open Payments data?

Achilles Theodore Paparsenos, M.D. has 160 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.